First Page | Document Content | |
---|---|---|
Glycosaminoglycans Oral and maxillofacial surgery Oral surgery Restylane Hyaluronan Lip enhancement Adverse event Food and Drug Administration Medical device Medicine Clinical research Pharmaceutical industry | Microsoft Word - Executive Summary-FDA-Final.docAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 208,12 KBShare Document on Facebook |